跳至主要内容
临床试验/NCT01405417
NCT01405417终止不适用

Endoscopic Peroral Myotomy for Treatment of Achalasia: Multicenter Study

Universitätsklinikum Hamburg-Eppendorf5 个研究点 分布在 4 个国家目标入组 70 人开始时间: 2011年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
70
试验地点
5
主要终点
Eckhard symptom score at 3 month after peroral endoscopic myotomy

研究概览

简要总结

This study intends to investigate the feasibility, safety and efficacy of peroral endoscopic myotomy for the treatment of achalasia in a multi center setting.

详细描述

This study intends to investigate the feasibility, safety and efficacy of peroral endoscopic myotomy for the treatment of achalasia in a multi center s

70 patients will be enrolled to evaluate feasibility, safety and efficacy of peroral endoscopic myotomy. Main outcome measurement is the Eckardt symptom score at 3 month after peroral endoscopic myotomy.

Primary outcome:

-Eckhard symptom score 3 month after therapy.

Secondary outcomes:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patient with symptomatic achalasia and pre-op barium swallow, manometry and esophagogastroduodenoscopy which are consistent with the diagnosis
  • •persons of age > 18 years with medical indication for surgical myotomy or Endoscopic balloon dilatation
  • •Signed written informed consent.

排除标准

  • •Patients with previous surgery of the stomach or esophagus
  • •Patients with known coagulopathy
  • •Previous achalasia-treatment with surgery
  • •Patients with liver cirrhosis and/or esophageal varices
  • •Active esophagitis
  • •Eosinophilic esophagitis
  • •Barrett's esophagus
  • •Pregnancy
  • •Stricture of the esophagus
  • •Malignant or premalignant esophageal lesion
  • •Candida esophagitis
  • •Hiatal hernia > 2cm

研究组 & 干预措施

Peroral endoscopic myotomy

Experimental

Patients with achalasia who are designed to either have balloon dilatation or botulinum toxine injection, or to have surgical intervention (Heller myotomy) for therapy.

Peroral endoscopic myotomy: A forward-viewing upper endoscope is used with a transparent distal cap attachment. Carbon dioxide gas is necessary for insufflation during the procedures. An endoscopic knife is used to access the submucosa, dissect the submucosal tunnel and also to divide circular muscle bundles over a length of approximately 10cm, extending 2-3cm onto the cardia. A electrogenerator is used with spray coagulation mode. A coagulating forceps is used for hemostasis as needed. Closure of the mucosal entry site is performed using standard endoscopic clips.

干预措施: Endoscopic Peroral Myotomy (Procedure)

结局指标

主要结局

Eckhard symptom score at 3 month after peroral endoscopic myotomy

时间窗: Score is evaluated at 3 month after peroral endoscopic myotomy

Validated symptom score based on dysphagia, pain, regurgitation and weight loss

次要结局

  • Lower esophageal sphincter pressure(Lower esophageal sphincter pressure is determined by manometry at 3 month after peroral endoscopic myotomy)
  • Reflux Symptoms(Reflux Symptoms are evaluated at 3 month after peroral endoscopic myotomy)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. Thomas Rösch

Prof. Dr. Thomas Roesch, Universitätsklinikum Hamburg-Eppendorf, Endoscopy department

Universitätsklinikum Hamburg-Eppendorf

研究点 (5)

Loading locations...

相似试验